|
|
Volumn 68, Issue 5, 2011, Pages 1285-1290
|
|
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
a
a
a
a
a
a
a
a
a
|
|
Author keywords
Child Pugh class; Hepatocellular carcinoma; Sorafenib
|
|
Indexed keywords
SORAFENIB;
ABDOMINAL PAIN;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALOPECIA;
ARTICLE;
CANCER CONTROL;
CANCER SURVIVAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE CLASSIFICATION;
DISEASE EXACERBATION;
DOSE LIVER FUNCTION RELATION;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
FATIGUE;
FEMALE;
HAND FOOT SYNDROME;
HUMAN;
HYPERTENSION;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA AND VOMITING;
NEUTROPENIA;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
RASH;
SIDE EFFECT;
SURVIVAL TIME;
THROMBOCYTOPENIA;
TREATMENT DURATION;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, HEPATOCELLULAR;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
PYRIDINES;
TREATMENT OUTCOME;
|
|
EID: 82455192245
PISSN: 03445704
EISSN: 14320843
Source Type: Journal
DOI: 10.1007/s00280-011-1616-x Document Type: Article |
|
Times cited : (71)
|
|
References (7)
|
